Free Cash Flow per Share: A measure of financial performance calculated as operating cash flow minus capital expenditures, expressed on a per share basis. Calculated as: Free Cash Flow / Weighted Average Shares Outstanding (Diluted)
Indivior Pharmaceuticals Inc. (INDV) had Free Cash Flow per Share of $-0.22 for the most recently reported fiscal quarter, ending 2026-03-31.
| Income Statement Financials | |
$317.00M |
|
$89.00M |
|
$40.00M |
|
$277.00M |
|
$180.00M |
|
$137.00M |
|
$-22.00M |
|
$115.00M |
|
$115.00M |
|
$89.00M |
|
$89.00M |
|
$89.00M |
|
$89.00M |
|
$137.00M |
|
$141.00M |
|
124.00M |
|
129.00M |
|
$0.71 |
|
$0.69 |
|
| Balance Sheet Financials | |
$667.00M |
|
$157.00M |
|
$530.00M |
|
$1.20B |
|
$779.00M |
|
$486.00M |
|
$562.00M |
|
$1.34B |
|
$-144.00M |
|
$-146.00M |
|
$-144.00M |
|
125.00M |
|
| Cash Flow Statement Financials | |
$-9.00M |
|
$-19.00M |
|
$7.00M |
|
$195.00M |
|
$175.00M |
|
$-20.00M |
|
$9.00M |
|
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
0.86 |
|
-- |
|
-- |
|
1.42 |
|
-3.38 |
|
87.38% |
|
43.22% |
|
43.22% |
|
-- |
|
36.28% |
|
28.08% |
|
$-29.00M |
|
-- |
|
-- |
|
-- |
|
0.26 |
|
0.26 |
|
1.11 |
|
80.91 |
|
-61.81% |
|
-60.96% |
|
7.44% |
|
26.02% |
|
$-1.15 |
|
|
Free Cash Flow per Share |
$-0.22 |
$-0.07 |
|